MiR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells

Cellular Physiology and Biochemistry

Volumn 32, Issue 2, 2013, Pages 448-458

  Li, Hangyu ^a   Li, Yan ^a   Liu, Dan ^a   Sun, Hongzhi ^b   Liu, Jingang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Celastrol; Migration and invasion; miR 224; MMPs; NF B

Indexed keywords

CELASTROL; GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 224; PROTEIN KINASE B; SOMATOMEDIN C; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUH7 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; METASTASIS INHIBITION; MIGRATION INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TUMOR INVASION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOPLASM INVASIVENESS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; TRITERPENES;

EID: 84885589594     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354450     Document Type: Article

References (28)

1. Venook AP, Papandreou C, Furuse J, de Guevara LL: The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. Oncologist 2010;15:5-13.
2. Ribatti D, Vacca A, Nico B, Sansonno D, Dammacco F: Angiogenesis and anti-angiogenes is in hepatocellular carcinoma. Cancer Treat Rev 2006;32:437-444.
3. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT: Biology of hepatocellular carcinoma. Ann Surg Oncol 2008;15:962-971.
4. Okazaki I, Inagaki Y: Novel strategies for hepatocellular carcinoma based on MMPs science. Anticancer Agents Med Chem 2012;12:753-763.
5. Inui M, Martello G, Piccolo S: MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010;11:252-263.
6. Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-568.
7. Davis-Dusenbery BN, Hata A: MicroRNA in cancer: the involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer 2010;1:1100-1114.
8. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA: MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 2009;9:293-302.
9. Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K: Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J Gastroenterol Hepatol 2013;28:565-575.
10. Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, Luo XZ, Wang D: MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration andinvasion. J Gastroenterol Hepatol 2010;25:164-171.
11. Scisciani C, Vossio S, Guerrieri F, Schinzari V, De Iaco R, D'Onorio de Meo P, Cervello M, Montalto G, Pollicino T, Raimondo G, Levrero M, Pediconi N: Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. J Hepatol 2012;56:855-861.
12. Salminen A, Lehtonen M, Paimela T, Kaarniranta K: Celastrol: Molecular targets of Thunder God Vine Biochem Biophys Res Commun 2010;394:439-442.
13. Morita T: Celastrol: a new therapeutic potential of traditional Chinese medicine. Am J Hypertens 2010;23:821.
14. Kannaiyan R, Shanmugam MK, Sethi G: Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 2011;303:9-20.
15. Kannaiyan R, Manu KA, Chen L, Li F, Rajendran P, Subramaniam A, Lam P, Kumar AP, Sethi G: Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 2011;16:1028-1041.
16. Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B: Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogenactivated protein kinase pathway. J Pharmacol Exp Ther 2010;334:489-499.
17. Kim Y, Kang H, Jang SW, Ko J: Celastrol inhibits breast cancer cell invasion via suppression of NF-κBmediated matrixmetalloproteinase-9 expression. Cell Physiol Biochem 2011;28:175-184.
18. Vermes I, Haanen C, Reutelingsperger C: Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243:167-190.
19. Gong F, Sun L, Wang Z, Shi J, Li W, Wang S, Han X, Sun Y: The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3'-UTR. Nucleic Acids Res 2011;39:4640-4652.
20. Mukhopadhyay A, Deplancke B, Walhout AJ, Tissenbaum HA: Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. Nat Protoc 2008;3:698-709.
21. Rajendran P, Li F, Shanmugam MK, Kannaiyan R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, Luk JM, Sethi G: Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev Res (Phila) 2012;5:631-643.
22. Li J, Lau G, Chen L, Yuan YF, Huang J, Luk JM, Xie D, Guan XY: Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression. PLoS One 2012;7:e46264.
23. Johansson N, Ahonen M, Kähäri VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000;57:5-15.
24. Gupta SC, Kim JH, Prasad S, Aggarwal BB: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cellsthrough modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010;29:405-434.
25. Zhu H, Yang W, He LJ, Ding WJ, Zheng L, Liao SD, Huang P, Lu W, He QJ, Yang B: Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells. PLoS One 2012;7:e52333.
26. Zhang D, Xu L, Cao F, Wei T, Yang C, Uzan G, Peng B: Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose-and cell type-dependent way. Cell Stress Chaperones 2010;15:939-946.
27. Ogasawara S, Yano H, Momosaki S, Nishida N, Takemoto Y, Kojiro S, Kojiro M: Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues. Oncol Rep 2005;13:1043-1048.
28. Rasul A, Ding C, Li X, Khan M, Yi F, Ali M, Ma T: Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53, and enhances apoptosis. Apoptosis 2012;17:1104-1119.